EverPoint Asset Management’s AbbVie ABBV Stock Holding History

EverPoint Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$18.8M	Buy	+300,000	New	+$18.3M	0.35%	70
2015 Q3	–	Sell	-300,000	Closed	-$20.2M	–	394
2015 Q2	$20.2M	Sell	300,000 -150,000	-33%	-$9.79M	0.37%	70
2015 Q1	$26.3M	Buy	+450,000	New	+$27.2M	0.5%	49
2014 Q4	–	Sell	-390,000	Closed	-$22.5M	–	443
2014 Q3	$22.5M	Buy	+390,000	New	+$21.7M	0.51%	45

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

EverPoint Asset Management's ABBV Position: Q4 2016 in Review

EverPoint Asset Management opened a new position in AbbVie (ABBV) in Q4 2016: 300,000 shares worth $18.8M. The stake represents 0.35% of the portfolio and ranks #70 among its holdings. This is a return to the name: EverPoint Asset Management previously reported a position in ABBV as recently as Q2 2015.

EverPoint Asset Management first reported a position in ABBV in Q3 2014 and has held it in 4 quarters since. The position peaked at $26.3M in Q1 2015. 1,691 funds tracked by Wall St. Rank hold ABBV as of Q4 2016.

EverPoint Asset Management held 300,000 shares of AbbVie worth $18.8M as of Q4 2016.
AbbVie was a new EverPoint Asset Management position in Q4 2016.
AbbVie made up 0.35% of EverPoint Asset Management's portfolio in Q4 2016, its #70 holding.
EverPoint Asset Management first reported a position in AbbVie in Q3 2014 and has held it in 4 quarters since.
EverPoint Asset Management's AbbVie position peaked at $26.3M in Q1 2015.
1,691 funds tracked by Wall St. Rank held AbbVie as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.